Synthetic MR AB (LTS:0G79) ROCE % : 9.07% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Synthetic MR AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Synthetic MR AB's annualized ROCE % for the quarter that ended in Mar. 2024 was 9.07%.

Synthetic MR AB ROCE % Historical Data

The historical data trend for Synthetic MR AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB ROCE % Chart

Synthetic MR AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

10.91

2.10

24.71

10.31

11.66

Synthetic MR AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-7.54	10.43	16.27	27.27	9.07

Synthetic MR AB ROCE % Calculation

Synthetic MR AB's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	13.133	/	( ( (127.432 - 19.041)	+	(142.965 - 26.158) )	/ 2 )
	=	13.133	/	( (108.391	+	116.807)	/ 2 )
	=	13.133	/	112.599
	=	11.66 %

Synthetic MR AB's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	10.748	/	( ( (142.965 - 26.158)	+	(146.163 - 26.055) )	/ 2 )
	=	10.748	/	( ( 116.807	+	120.108 )	/ 2 )
	=	10.748	/	118.4575
	=	9.07 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Synthetic MR AB (LTS:0G79) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Synthetic MR AB ROCE % Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Synthetic MR AB (LTS:0G79) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (LTS:0G79) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

SYNT:Sweden

Address

Storgatan 11, Linkoping, SWE, SE-582 23

Website

https://www.syntheticmr.com

Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (LTS:0G79) Headlines

No Headlines